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Letter: low population mortality from COVID-19 in countries 
south of latitude 35 degrees North supports vitamin D as a 
factor determining severity
EDITORS,
The recent editorial by Rhodes et al considered latitude and men-
tioned one mechanism that vitamin D is important in regulating and 
suppressing the inflammatory response of cytokines of respiratory 
epithelial cells and macrophages to various pathogens, including res-
piratory viruses and preventing cytokine storm and the subsequent 
acute respiratory distress syndrome (RDS).1
It is appropriate to add the induction of the antimicrobial peptide 
cathelicidin with anti-viral action,2,3 and other beneficial mechanism 
of vitamin D including inhibition of the renin-angiotensin system 
(RAS) with inhibition of AT1R receptor, and stimulation of ACE2, the 
enzyme to which coronavirus binds and inhibits. This enzyme trans-
forms angiotensin II into angiotensin (1-7), which is vasodilatory and 
hypotensive. This step, beneficial in these circumstances, is inhibited 
by SARS-CoV-2 and stimulated by vitamin D.
Lin reported that the renoprotective effect of calcitriol was due 
to the action on ACE, ACE2 and the ratio between both.4 Xu demon-
strated in rats with RDS that calcitriol pre-treatment inhibited renin, 
ACE and angiotensin II, but induced ACE2, and resulted in clinical 
improvement.5 Gatera reviewed available evidence on vitamin D 
supplementation in animals and humans with RDS, and concluded 
that it was effective.6
In conclusion, both mechanisms may play a beneficial role in the 
action of vitamin D in COVID-19 infection—stimulation of the im-
mune system and inhibition of RAS by stimulating ACE2.
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